Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: ComradeBrehznev who wrote (51429)	7/20/1999 11:15:00 AM
From: Dotty	Read Replies (1) \| Respond to of 120523

DISH??? Anyone know what is with DISH (I do not own it!) It's DOWN -86 11/16 at 75 1/2!!! I can't find any news?!

To: ComradeBrehznev who wrote (51429)	7/20/1999 11:32:00 AM
From: Mel Spivak	Respond to of 120523

PLMD has been coming up slowly & just released GREAT earnings: PolyMedica's First Quarter EPS Rises 92% to $0.25 On a 53% Revenue Gain Expansion Strategy Continues to Deliver Record Results WOBURN, MA--(BUSINESS WIRE)--July 20, 1999--PolyMedica Corporation (NNM: PLMD) today reported record across-the-board consolidated results for the fiscal first quarter ended June 30, 1999. Accelerating customer shipments in the Company's direct-to-consumer diabetes supplies business is fueling the very strong start for fiscal 2000. For the fiscal first quarter, net revenues rose 53% to $31.6 million, from $20.7 million in the same period a year earlier. Income from operations increased 68% to $4.5 million, from $2.7 million in the year-earlier quarter. Net income rose 90% to $2.5 million, or $0.25 per share (diluted), from $1.3 million, or $0.13 per share (diluted), in the first quarter of fiscal l999. The Company generated $1.9 million in positive operating cash flow versus $539,000 during the entire fiscal 1999 year. This is the tenth quarter of profitable growth in comparable periods. Chairman and CEO Steven J. Lee noted that the Company shipped to a record number of customers in the first quarter, solidifying its position as the nation's #1 provider of direct-to-consumer diabetes supplies and services. Commenting further on PolyMedica's first quarter performance, Mr. Lee said, ''The continuing very strong momentum in our home delivery business reflects our marketing and service expertise and the ever increasing incidence of diabetes among seniors. Through our direct response advertising, we have developed the most extensive proprietary database of diabetic seniors in the US. Our highly trained service force provides 24 hour-a-day assistance geared to the special needs of seniors with chronic medical conditions. In July 1999, we added pharmacy service for diabetic customers who also suffer from asthma and other respiratory conditions. We will continue to capitalize on our marketing and service strengths to expand our direct-to-consumer business in diabetes and related categories.'' The Company continues to lead its OTC market segment with its popular AZO brand line of female urinary tract discomfort products. In April 1999, the AZO line was expanded to five distinctive products with the introduction of AZO Menopause(TM), for relief from hot flashes and associated symptoms, and AZO Confidence(TM), for temporary relief of incontinence. PolyMedica is best known through its subsidiaries and product lines. The Company's Liberty Medical Supply, Inc. subsidiary is the leading direct mail provider of diabetes testing supplies to seniors who have Medicare coverage. Liberty offers approximately 200 brand-name products from a full range of manufacturers. The Company's AZO line of products has risen to a 47% share of the over-the-counter female urinary tract discomfort market. PolyMedica also is the leading manufacturer and distributor of private-label digital thermometers and has the number two overall market position in thermometers. For more information on PolyMedica, please contact our web site at polymedica.com. This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, changes in Medicare reimbursement, fluctuations in customer demand, management of rapid growth, intensity of competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions and regulatory changes, as well as other especially relevant risks detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended March 31, 1999, and the information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release.